JTCS St. Jude Medical
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsubara, T.
Right arrow Articles by Nishi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsubara, T.
Right arrow Articles by Nishi, M.

J Thorac Cardiovasc Surg 1994;107:1073-1078
© 1994 Mosby, Inc.


GENERAL THORACIC SURGERY

How extensive should lymph node dissection be for cancer of the thoracic esophagus?

Toshiki Matsubara, MD, Mamoru Ueda, MD, Osamu Yanagida, MD, Toshifusa Nakajima, MD, Mitsumasa Nishi, MD


Tokyo, Japan

Supported by grants-in-aid for cancer research (No. 1-34) from the Ministry of Health and Welfare, Japan.

Received for publication June 14, 1993. Accepted for publication Aug. 19, 1993. Address for reprints: Toshiki Matsubara, MD, Department of Surgery, Cancer Institute Hospital, 1-37-1 Kami-Ikebukuro, Toshima-Ku, Tokyo 170, Japan.

Abstract

From 1985 to 1992, 171 patients with cancer of the thoracic esophagus underwent esophagectomy with systematic dissection of regional lymph nodes including cervical nodes. The hospital mortality rate was 5.3%. The dissected nodes were classified into four groups: the deep cervical (C), upper mediastinal and cervical paratracheal (U), middle and lower mediastinal (L), and upper perigastric (G) groups. The U group mainly consisted of nodes beside the recurrent laryngeal nerves. The phase of cancer infiltration of lymph nodes was evaluated by the total number and the distribution of involved nodes. Of cases with nodal involvement, only 37% were in the late phase, in which more than seven nodes or in which the U, L, and G groups were all involved. Of cases in the earliest phase in which only one node was involved, 93% had either the U or G group involved. The C group of nodes was infrequently involved until the late phase. Cancer had metastasized to the U and G groups across a considerable anatomic distance even in earlier phases. Outcomes of the cases with nodal involvement not in the late phase were satisfactory; the cumulative survival was 60% at 3 years and 54% at 5 years. Systematic nodal dissection would benefit even cases with nodal involvement, unless the disease is in the late phase. Nodes beside the recurrent nerves and upper perigastric nodes should be dissected with higher priority, though they are located anatomically distant. (J THORACCARDIOVASCSURG1994;107:1073-8)




This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
S. Komatsu, Y. Ueda, D. Ichikawa, H. Fujiwara, K. Okamoto, S. Kikuchi, A. Shiozaki, K. Imura, R. Ohsawa, T. Ochiai, et al.
Prognostic and Clinical Evaluation of Axillary Lymph Node Metastasis in Esophageal Cancer
Jpn. J. Clin. Oncol., April 1, 2007; 37(4): 314 - 318.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
D. W. Gee and D. W. Rattner
Management of Gastroesophageal Tumors
Oncologist, February 1, 2007; 12(2): 175 - 185.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
W. Schroder, S.P. Monig, S.E. Baldus, C. Gutschow, P.M. Schneider, and A.H. Holscher
Frequency of Nodal Metastases to the Upper Mediastinum in Barrett's Cancer
Ann. Surg. Oncol., October 1, 2002; 9(8): 807 - 811.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
K. Hayashi, N. Ando, H. Watanabe, H. Ide, K. Nagai, N. Aoyama, W. Takiyama, K. Ishida, K. Isono, H. Makuuchi, et al.
Phase II Evaluation of Protracted Infusion of Cisplatin and 5-Fluorouracil in Advanced Squamous Cell Carcinoma of the Esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407)
Jpn. J. Clin. Oncol., September 1, 2001; 31(9): 419 - 423.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C.-H. Shih, S. Ozawa, N. Ando, M. Ueda, and M. Kitajima
Vascular Endothelial Growth Factor Expression Predicts Outcome and Lymph Node Metastasis in Squamous Cell Carcinoma of the Esophagus
Clin. Cancer Res., March 1, 2000; 6(3): 1161 - 1168.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
T. Matsubara, M. Ueda, T. Nakajima, K. Nakagawa, T. Yamashita, N. Horikoshi, and A. Yanagisawa
Can Esophagectomy Cure Cancer of the Thoracic Esophagus Involving the Major Airways?
Ann. Thorac. Surg., January 1, 1995; 59(1): 173 - 177.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The American Association for Thoracic Surgery.